Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Technology · ·
$1.01
▲ $0.11 (+12.2%)
Market data updated: 09/24 05:48 AM
Fundamentals updated: 09/24/2026
News analyzed: 09/24/2026
Market Cap
$107.81M
Day Range
$0.89 - $1.01
52-Week Range
$0.61 - $4.24
Beta
—
Next Earnings
04.11.2026
Support
$0.61
Resistance
$1.22
DH is a stock from the Technology sector — Software, hardware, chip, and computing-services companies — revenue tied to the pace of innovation and upgrade cycles.
-76.5% (1Y)
Strengths: 11/30 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟡 Mixed
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
DCF Fair Value
Estimated fair value: $5.53 vs. price $1.01 (+447.6%)
Fair Value
Biggest negative driver
Operating margin
Operating margin: -93.1% (negative)
Fundamental
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
50
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
20d ago · $1.04
Evidence: Euphoria score crossed 55 (now 61)
What happened after
20d ago · $1.04
Evidence: FOMO score jumped from 72 to 97 day-over-day
What happened after
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
54
Quality
42
Value
62
Momentum
52
Risk
40
Sentiment
68
Fundamental
35
Institutional
No data available
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Definitive Healthcare Corp. has centered on two key developments: first, Advent International’s non-binding proposal to acquire the company at $1.02 per share, triggering a 13% stock surge and prompting the board to form a special committee to evaluate the offer; second, the company’s announcement that Clay Ritchey will succeed Kevin Coop as CEO on September 8, 2026, bringing over 25 years of healthcare experience to the role. Both moves reflect strategic shifts amid potential corporate restructuring.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Definitive Healthcare Corp.. News trend score: 68. Reason: 6 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
17
🎯 Conviction (vs. Emotion)
36
Psychology
19
Fundamentals
35
Technical
52
Valuation
62
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+61%
Market Narrative
36
Fundamental Reality
36
Narrative Gap
+0
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market’s extreme FOMO (score 90) is fueled by rapid price gains, elevated volume, and overbought conditions, while euphoria and overconfidence linger due to valuation disconnects. Confirmation bias persists as narrative optimism diverges from stagnant fundamentals. The key question is whether momentum can sustain itself or if the gap between price and fundamentals will eventually correct. The absence of panic selling or herding suggests a disciplined but aggressive buying environment, though volatility remains a potential wildcard.
Updated: 09/09/2026, 02:58 PM
What could change this?
👥 What the crowd believes
"Advent International submitted a non-binding proposal to acquire shares and units for $1.02-per-share"
"Definitive Healthcare Corp. appointed Clay Ritchey as CEO, succeeding Kevin Coop"
📈 12D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Benjamin Graham (Enterprising Investor) — 93/100
🔴 Weakest match
Philip Fisher — 7/100
🗣️ Why do they disagree?
Based on Benjamin Graham’s documented principles, the model estimates a deep statistical discount for DH, reflected in his Enterprising (93) and Defensive (86) scores, making it an attractive value candidate. Howard Marks’ framework rates the stock at 76 and 72, suggesting risk is reasonably priced and the market cycle is not overextended, though with less conviction than Graham. Mid‑range scores from Charles Mackay (64), Peter Lynch (59), Jesse Livermore (59) and Thorstein Veblen (56) indicate mixed signals of crowd excitement and growth that may already be priced in. Lower scores from Walter Bagehot (49) down to Philip Fisher (7) highlight concerns about liquidity, volatility, stability and quality, leading those methodologies to view the stock as marginal or risky. Consequently, value‑oriented investors see a compelling discount, while growth, quality and cycle‑sensitive approaches arrive at more cautious or negative conclusions.
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟢 93
Deep statistical discount — a real Enterprising Investor candidate
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 83
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 82
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 76
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 73
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟡 57
Mixed — growth exists but the price already reflects much of it
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 56
Adequate but not exceptional liquidity
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 56
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 53
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟡 52
Mid-cycle — no strong signal either way
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 39
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 36
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 35
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🔴 30
Doesn't show the stability Smith's long-term case requires
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 19
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 7
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Based on the last 282 trading days, calculated from real price data. Click an indicator for details and a chart.
🟡 Indicators are mixed — no clear bias (5 bullish · 5 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Low confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
75.9%
Operating Margin
-93.1%
Net Margin
-57.5%
EBITDA Margin
—
ROE
-49.4%
ROA
-18.9%
ROIC
—
EPS
-$1.30
Cash
$163.63M
Total Debt
$164.84M
Current Ratio
1.64
Debt/Equity
0.59
How is Fair Value calculated? →
Current Price
$1.01
Estimated Fair Value (DCF)
$5.53
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+447.6%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
3.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 3.0% | $38.17M | $35.02M |
| 2 | 2.9% | $39.27M | $33.05M |
| 3 | 2.7% | $40.34M | $31.15M |
| 4 | 2.6% | $41.40M | $29.33M |
| 5 | 2.5% | $42.44M | $27.58M |
Base FCF (last actual year)
$37.06M
Terminal Value
$669.22M
Present Value of Terminal Value
$434.95M
Enterprise Value
$591.08M
Net Debt
$1.21M
Equity Value
$589.87M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$1.97
Tangible Book Value per Share (Tangible NAV)
$0.24
Sentiment based on basic keywords (not AI) — 6 positive, 11 neutral, 3 negative out of the last 20 articles.
ChartMill · 2.9.2026
Yahoo · 2.9.2026
InvestorsHub · 2.9.2026
MT Newswires · 2.9.2026
Yahoo · 2.9.2026
GlobeNewswire · 2.9.2026
Benzinga · 2.9.2026
MT Newswires · 2.9.2026
Yahoo · 2.9.2026
Benzinga · 2.9.2026
Motley Fool · 18.8.2026
MT Newswires · 12.8.2026
SeekingAlpha · 11.8.2026
Moby · 11.8.2026
MT Newswires · 11.8.2026
Benzinga · 11.8.2026
GuruFocus.com · 11.8.2026
MarketBeat · 10.8.2026
Zacks · 10.8.2026
ChartMill · 10.8.2026
Definitive Healthcare Corp. (DH) currently has a StockIQ AI score of 50/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
DH currently scores 50/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, DH's estimated fair value is $5.53, which is 447.6% above the current price of $1.01. This is one valuation model among several signals in the fair-value category, not a price target.
DH's technical score is 52/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Estimated fair value: $5.53 vs. price $1.01 (+447.6%); Earnings per share (EPS) growth: 63.3%; Net income growth: 66.4%.
Based on the real signals StockIQ computed: Operating margin: -93.1% (negative); Net margin: -57.5% (negative); Operating margin is eroding over time.
StockIQ has no recorded dividend payment history for DH.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Heller Casey | Tax Withholding in Shares | 1.9.2026 | 41,093 | -41,093 | $0.90 |
| Krantz Jason Ronald | Tax Withholding in Shares | 1.8.2026 | 12,166 | -12,166 | $0.68 |
| Heller Casey | Tax Withholding in Shares | 1.8.2026 | 1,881 | -1,881 | $0.68 |
| Heller Casey | Tax Withholding in Shares | 1.8.2026 | 1,839,595 | -1,881 | $0.68 |
| Krantz Jason Ronald | Tax Withholding in Shares | 1.8.2026 | 1,189,272 | -12,166 | $0.68 |
| Coop Kevin | Tax Withholding in Shares | 1.7.2026 | 37,593 | -37,593 | $0.80 |
| Paris Jonathan | Tax Withholding in Shares | 1.7.2026 | 30,591 | -30,591 | $0.80 |
| Paris Jonathan | Tax Withholding in Shares | 1.7.2026 | 872,263 | -30,591 | $0.80 |
| Coop Kevin | Tax Withholding in Shares | 1.7.2026 | 4,975,229 | -37,593 | $0.80 |
| Winters Kathleen A | Grant/Award from Employer | 4.6.2026 | 189,190 | +189,190 | — |
| Stephenson Scott G | Grant/Award from Employer | 4.6.2026 | 189,190 | +189,190 | — |
| Chilukuri Sastry | Grant/Award from Employer | 4.6.2026 | 189,190 | +189,190 | — |
| Hamood Samuel A | Grant/Award from Employer | 4.6.2026 | 189,190 | +189,190 | — |
| Winters Kathleen A | Grant/Award from Employer | 4.6.2026 | 308,982 | +189,190 | — |
| Stephenson Scott G | Grant/Award from Employer | 4.6.2026 | 313,314 | +189,190 | — |
| Chilukuri Sastry | Grant/Award from Employer | 4.6.2026 | 315,984 | +189,190 | — |
| Hamood Samuel A | Grant/Award from Employer | 4.6.2026 | 289,396 | +189,190 | — |
| Coop Kevin | Tax Withholding in Shares | 1.6.2026 | 66,050 | -66,050 | $0.99 |
| Heller Casey | Tax Withholding in Shares | 1.6.2026 | 164,377 | -164,377 | $0.99 |
| Coop Kevin | Tax Withholding in Shares | 1.6.2026 | 5,012,822 | -66,050 | $0.99 |
| Heller Casey | Tax Withholding in Shares | 1.6.2026 | 1,841,476 | -164,377 | $0.99 |
| Heller Casey | Tax Withholding in Shares | 1.5.2026 | 1,469 | -1,469 | $0.99 |
| Krantz Jason Ronald | Tax Withholding in Shares | 1.5.2026 | 12,166 | -12,166 | $0.99 |
| Heller Casey | Tax Withholding in Shares | 1.5.2026 | 2,005,853 | -1,469 | $0.99 |
| Krantz Jason Ronald | Tax Withholding in Shares | 1.5.2026 | 1,201,438 | -12,166 | $0.99 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,985,563 shares short as of 2026-08-31 · vs. 1,967,457 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
33.7% of trading volume this week was short selling, vs. 26.3% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology